IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein
Open Access
- 7 May 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9), 4951
- https://doi.org/10.3390/ijms22094951
Abstract
Diagnostic evaluation of specific antibodies against the SARS-CoV-2 virus is mainly based on spike (S) and nucleocapsid (N) proteins. Despite the critical functions in virus infection and contribution to the pattern of immunodominance in COVID-19, exploitation of the most abundant membrane (M) protein in the SARS-CoV-2 serology tests is minimal. This study investigated the recombinant M protein’s immunoreactivity with the sera from COVID-19 convalescents. In silico designed protein was created from the outer N-terminal part (19 aa) and internal C-terminal tail (101–222 aa) of the M protein (YP_009724393.1) and was recombinantly produced and purified. The designed M protein (16,498.74 Da, pI 8.79) revealed both IgM and IgG reactivity with serum samples from COVID-19 convalescents in Western blot. In ELISA, more than 93% (28/30) of COVID-19 sera were positive for IgM detection, and more than 96% (29/30) were positive for specific IgG detection to M protein. Based on the capacity to provoke an immune response and its strong antigenic properties, as shown here, and the fact that it is also involved in the virion entry into host cells, the M protein of the SARS-CoV-2 virus as a good antigen has the potential in diagnostic purposes and vaccine design.Keywords
Funding Information
- Ministry of Education and Technological Development, Republic of Serbia (451-03-9/2021-14/200168, 451-03-68/2020-14/200019)
This publication has 36 references indexed in Scilit:
- Serological assays for emerging coronaviruses: Challenges and pitfallsVirus Research, 2014
- A structural analysis of M protein in coronavirus assembly and morphologyJournal of Structural Biology, 2011
- The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T‐Lymphocyte EpitopesThe Journal of Infectious Diseases, 2010
- Establishment of a reference panel for the detection of anti-SARS-CoV antibodiesBiologicals, 2007
- Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteinsJournal of Virological Methods, 2005
- Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated CoronavirusJournal of Clinical Microbiology, 2005
- Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccineJournal of General Virology, 2004
- BEPITOPE: predicting the location of continuous epitopes and patterns in proteinsJournal of Molecular Recognition, 2003
- Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicineClinical Chemistry, 1993
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978